3-methylquercetin and formononetin

Albiziae Flos (AF) has been experimentally proven to have an antidepressant effect. However, due to the complexity of botanical ingredients, the exact pharmacological mechanism of action of AF in depression has not been completely deciphered. This study used the network pharmacology method to construct a component-target-pathway network to explore the active components and potential mechanisms of action of AF. The methods included collection and screening of chemical components, prediction of depression-associated targets of the active components, gene enrichment, and network construction and analysis. Quercetin and 4 other active components were found to exert antidepressant effects mainly via monoaminergic neurotransmitters and cAMP signaling and neuroactive ligand-receptor interaction pathways. DRD2, HTR1A, and SLC6A4 were identified as important targets of the studied bioactive components of AF. This network pharmacology analysis provides guidance for further study of the antidepressant mechanism of AF.

Topics: Albizzia; Antidepressive Agents; Gene Regulatory Networks; Humans; Isoflavones; Kaempferols; Luteolin; Phytochemicals; Plant Extracts; Quercetin; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Serotonin Plasma Membrane Transport Proteins; Signal Transduction

Enterovirus 71 (EV71) infection is known to cause hand, foot, and mouth disease (HFMD), which is associated with neurological complications; however, there is currently no effective treatment for this infection. Flavonoids are a large group of naturally occurring compounds with multiple bioactivities, and the inhibitory effects of several flavonoids against EV71 have been studied in cell cultures; however, to date, there are no reported data on their effects in animal models. In this study, we confirmed the in vitro activities of eight flavonoids against EV71 infection, based on the inhibition of cytopathic effects. Moreover, these flavonoids were found to reduce viral genomic RNA replication and protein synthesis. We further demonstrated the protective efficacy of these flavonoids in newborn mice challenged with a lethal dose of EV71. Apigenin, luteolin, kaempferol, formononetin, and penduletin conferred survival protection of 88.89%, 91.67%, 88.89%, 75%, and 66.67%, respectively, from the lethal EV71 challenge. In addition, isorhamnetin provided the highest mice survival protection of 100% at a dose of 10 mg/kg. This study, to the best of our knowledge, is the first to evaluate the in vivo anti-EV7l activities of multiple flavonoids, and we accordingly identified flavonoids as potential leading compounds for anti-EV71 drug development.

Topics: Animals; Animals, Newborn; Antiviral Agents; Apigenin; Cell Line; Cytopathogenic Effect, Viral; Disease Models, Animal; Enterovirus A, Human; Enterovirus Infections; Female; Flavonoids; Humans; Isoflavones; Kaempferols; Luteolin; Mice; Mice, Inbred BALB C; Protective Agents; Quercetin; Survival Rate; Virus Replication

To establish a method to determine the concentration of formononetin, calycosin and isorhamnetin from Astragalus mongholicus in rats' plasma using LC-MS/MS and calculate their pharmacokinetic parameters.. The contents of formononetin, calycosin and isorhamnetin in plasma were detected before and 24 h after 10 rats were treated with 10 g/kg Astragalus mongholicus. Rutin was used as internal standard. Agilent 1 200 HPLC system with Alltima C18 (150 mm x 2.1 mm, 5 microm) was used. Mobile phase was methanol-water solution with gradient elute at a flow rate of 0.3 mL/min. The column temperature was 40 degrees C. The LC-MS/ MS system was operated using an electrospray ionization probe in negative ion mode; Scan mode: multiple reaction ion monitoring (MRM) mode. The ion of monitor: m/z 267.0 --> 251.9 for formononetin, m/z 283.1 --> 268.2 for calycosin, m/z 315.4 --> 300.1 for isorhamnetin and m/z 609.4 --> 300.1 for rutin (internal standard), respectively.. The linear range of formononetin, calycosin and isorhamnetin was 5 - 1 000 (r = 0.9996), 3.91 - 500 (r = 0.9989) and 0.5 - 100 ng/mL (r = 0.9992), respectively. The lowest limit of quantification (LLOQ) of formononetin, calycosin and isorhamnetin was 0.625, 0.5 and 0.1 ng/mL, respectively. The pharmacokinetic parameter, t(1/2beta), of formononetin, calycosin and isorhamnetin was (10.43 +/- 2.94), (6.91 +/- 1.33) and (5.07 +/- 1.21) h, respectively. The C(max) of formononetin, calycosin and isorhamnetin was (398.5 +/- 103.7), (138.7 +/- 32.8) and (58.3 +/- 14.5) ng/mL, respectively. The AUC(0 -> 12h), of formononetin, calycosin and isorhamnetin was (1238.8 +/- 311.3), (669.5 +/- 159.7) and (274.1 +/- 83.9)ng x h/mL, respectively.. A sensitive, accuracy and suitable LC-MS/MS method for determination of formononetin, calycosin and isorhamnetin is developed and successfully applied to the pharmacokinetic study of 10 g/kg Astragalus mongholicus after oral administration in rats.

Topics: Administration, Oral; Animals; Astragalus Plant; Chromatography, Liquid; Isoflavones; Male; Quercetin; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tandem Mass Spectrometry